| Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients DM Salerno, DL Jennings, NW Lange, D Kovac, T Shertel, JK Chen, ... American Journal of Transplantation 22 (8), 2083-2088, 2022 | 76 | 2022 |
| Nirmatrelvir/ritonavir use: managing clinically significant drug-drug interactions with transplant immunosuppressants NW Lange, DM Salerno, DL Jennings, J Choe, J Hedvat, DB Kovac, ... American Journal of Transplantation 22 (7), 1925-1926, 2022 | 70 | 2022 |
| COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA. 1 era J Hedvat, NW Lange, DM Salerno, EM DeFilippis, D Kovac, H Corbo, ... American Journal of Transplantation 22 (11), 2682-2688, 2022 | 41 | 2022 |
| Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis DL Jennings, N Lange, M Shullo, F Latif, S Restaino, VK Topkara, ... International journal of cardiology 265, 71-76, 2018 | 39 | 2018 |
| Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction NW Lange, DM Salerno, CM Sammons, AB Jesudian, EC Verna, ... Clinical Transplantation 32 (12), e13415, 2018 | 17 | 2018 |
| Bebtelovimab for treatment of COVID-19 in ambulatory solid organ transplant recipients T Shertel, NW Lange, DM Salerno, J Hedvat, DL Jennings, JY Choe, ... Transplantation 106 (10), e463-e464, 2022 | 15 | 2022 |
| Nitazoxanide treatment for norovirus infection in solid organ transplant recipients J Hedvat, DM Salerno, D Kovac, JL Scheffert, H Corbo, JK Chen, JY Choe, ... Clinical transplantation 36 (3), e14594, 2022 | 14 | 2022 |
| Immunosuppression considerations in simultaneous organ transplant D Kovac, J Choe, E Liu, J Scheffert, J Hedvat, A Anamisis, D Salerno, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (1 …, 2021 | 14 | 2021 |
| Management of hepatic coagulopathy in bleeding and nonbleeding patients: an evidence-based review NW Lange, DM Salerno, K Berger, MM Cushing, RS Brown Jr Journal of Intensive Care Medicine 36 (5), 524-541, 2021 | 12 | 2021 |
| Using known drug interactions to manage supratherapeutic calcineurin inhibitor concentrations NW Lange, DM Salerno, K Berger, DS Tsapepas Clinical Transplantation 31 (11), e13098, 2017 | 10 | 2017 |
| Managing the significant drug-drug interaction between tacrolimus and letermovir in solid organ transplant recipients J Hedvat, JY Choe, DM Salerno, JL Scheffert, D Kovac, A Anamisis, ... Clinical transplantation 35 (3), e14213, 2021 | 9 | 2021 |
| Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients DM Salerno, ME Thornberg, NW Lange, J Hedvat, H Robbins, RS Brown, ... Clinical Transplantation 35 (12), e14396, 2021 | 6 | 2021 |
| Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients DC Sabatino, J Hedvat, DM Salerno, MR Pereira, NW Lange Clinical Transplantation 37 (4), e14929, 2023 | 4 | 2023 |
| Elevated posaconazole trough concentrations are not associated with increased risk for posaconazole toxicity in lung transplant recipients DC Sabatino, NW Lange, DM Salerno, J Scheffert Clinical Transplantation 37 (1), e14826, 2023 | 4 | 2023 |
| Comparing weight‐based dosing of tacrolimus XR in obese and non‐obese renal transplant recipients NT Breslin, J Hedvat, DM Salerno, N Jandovitz, C Patel, S Lee, NW Lange Clinical Transplantation 36 (2), e14529, 2022 | 4 | 2022 |
| An evaluation of PJP prophylaxis and anemia among renal transplant recipients J Hedvat, N Poladi, DM Salerno, GK Dube, NW Lange Transplant Infectious Disease 23 (3), e13543, 2021 | 2 | 2021 |
| Maribavir does not significantly influence tacrolimus dose requirements in solid organ transplant recipients. DC Sabatino, J Hedvat, DM Salerno, NW Lange Transplant Infectious Disease 24 (4), 2022 | 1 | 2022 |
| Deceased donor renal transplantation in patients on apixaban at time of transplant surgery: A case series NW Lange, JH Lee, EC Liu, J Hedvat, J Weiner, S Sultan Clinical Transplantation 35 (1), e14148, 2021 | 1 | 2021 |
| Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients. NW Lange, J Hedvat, DS Tsapepas, DM Salerno | 1 | 2020 |
| Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients M Thornberg, J Scheffert, D Jennings, J Hedvat, N Lange, H Robbins, ... AMERICAN JOURNAL OF TRANSPLANTATION 20, 1003-1003, 2020 | 1 | 2020 |
